![Laura Sepp-Lorenzino](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 866 082 $ al 30/06/2026
La Dra. Laura Sepp-Lorenzino es directora independiente de Taysha Gene Therapies, Inc. y directora científica y vicepresidenta ejecutiva de Intellia Therapeutics, Inc. Forma parte del Consejo de Administración de Taysha Gene Therapies, Inc. La Dra. Sepp-Lorenzino trabajó anteriormente como Vicepresidenta, Jefa de Terapias de Ácidos Nucleicos e Investigación en Vertex Pharmaceuticals, Inc. y Vicepresidenta en Alnylam Pharmaceuticals, Inc. y Directora Ejecutiva y Jefa de Terapias de ARN en Merck & Co. Se licenció en la Universidad de Buenos Aires, se graduó en la Universidad de Nueva York y se doctoró en la Universidad de Nueva York.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 01/06/2026 | 127.178 ( 0,05 % ) | 866 082 $ | 30/06/2026 | |
| 28/04/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| TAYSHA GENE THERAPIES, INC. | Director/Miembro de la Junta | 23/11/2020 |
| LEXEO THERAPEUTICS, INC. | Director/Miembro de la Junta | 28/04/2026 |
Oligonucleotide Therapeutics Society, Inc.
 Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit forum for research and development of oligonucleotide therapeutics | Director/Miembro de la Junta | - |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
| INTELLIA THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 13/01/2025 |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01/05/2019 |
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/09/2017 |
| MERCK & CO., INC. | Director/Miembro de la Junta | 01/03/2014 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universidad de Buenos Aires
 Universidad de Buenos Aires Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit forum for research and development of oligonucleotide therapeutics | Commercial Services |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Intellia Therapeutics, Inc.
 Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
Taysha Gene Therapies, Inc.
 Taysha Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes adeno-associated viruses-based gene therapies for the treatment of monogenic diseases of the central nervous system | Health Technology |
Lexeo Therapeutics Inc
 Lexeo Therapeutics Inc BiotechnologyHealth Technology Develops gene therapy to treat genetic diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
